Cargando…

Vaccination of Rats Against the Yoshida Ascites Sarcoma with the Formation of Complement-Fixing Antibody

Detalles Bibliográficos
Autor principal:	Lund, Helge J. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1957
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073875/ https://www.ncbi.nlm.nih.gov/pubmed/13499798

Ejemplares similares

The Absorption, Distribution and Excretion of (3)H-Chlorambucil in Rats Bearing the Yoshida Ascites Sarcoma
por: Hill, Bridget T., et al.
Publicado: (1971)

Isolation of Genes Differentially Expressed between the Yoshida Sarcoma and Long‐survival Yoshida Sarcoma Variants: Origin of Yoshida Sarcoma Revisited
por: Tsuchiya, Haruo, et al.
Publicado: (1994)

Anti-Tumour Activity of the Fluorescent Dye, Acridine Orange, on Yoshida Sarcoma (Ascites)
por: Korgaonkar, K. S., et al.
Publicado: (1963)

Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).
por: Dessí, S., et al.
Publicado: (1992)

The nature of the resistance to methylene dimethane sulphonate in the Yoshida sarcoma.
por: Fox, B. W., et al.
Publicado: (1973)

The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
por: Harrap, K. R., et al.
Publicado: (1969)

Comparison of Oxygen Tensions in Normal Tissues and Yoshida Sarcoma of the Rat Breathing Air or Oxygen at 4 Atmospheres
por: Jamieson, Dana, et al.
Publicado: (1963)

First person – Nagisa Yoshida
Publicado: (2020)

Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
por: Dessì, S., et al.
Publicado: (1995)

A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells
por: Szende, B., et al.
Publicado: (1973)

The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
por: Harrap, K. R., et al.
Publicado: (1969)

Influence of tumour volume and cell kinetics on the response of the solid Yoshida sarcoma to hyperthermia (42 degrees C).
por: Calderwood, S. K., et al.
Publicado: (1980)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
por: Csányi, E., et al.
Publicado: (1967)

Targets of complement-fixing antibodies in protective immunity against malaria in children
por: Reiling, Linda, et al.
Publicado: (2019)

Optimization of Bacterial Plasmid Transformation Using Nanomaterials Based on the Yoshida Effect
por: Tan, Haidong, et al.
Publicado: (2010)

EFFECT OF ANTIBODY AND COMPLEMENT ON PERMEABILITY CONTROL IN ASCITES TUMOR CELLS AND ERYTHROCYTES
por: Green, H., et al.
Publicado: (1959)

NEUTRALIZING AND COMPLEMENT-FIXING ANTIBODY PRODUCTION AND RESISTANCE FOLLOWING VACCINATION IN EXPERIMENTAL ENCEPHALITIS INFECTIONS
por: Casals, J.
Publicado: (1943)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus
por: Nascimento, Eduardo J. M., et al.
Publicado: (2021)

STUDIES ON THE ANTIGENIC PROPERTIES OF COMPLEMENT : I. DEMONSTRATION OF AGGLUTINATING ANTIBODIES AGAINST GUINEA PIG COMPLEMENT FIXED ON SENSITIZED SHEEP ERYTHROCYTES
por: Klein, Paul G., et al.
Publicado: (1960)

Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria
por: Boyle, Michelle J., et al.
Publicado: (2015)

Electron spin resonance study of changes during development of solid Yoshida tumour. I: Ascorbyl radical.
por: Silcock, J. M., et al.
Publicado: (1976)

Occurrence of Cis-11,12-Methylene-Hexadecanoic Acid in the Red Alga Solieria pacifica (Yamada) Yoshida
por: Kim, Gwang-Woo, et al.
Publicado: (2021)

Electron spin resonance study of changes during development of solid yoshida tumour. II. Paramagnetic metal ions.
por: Dodd, N. J., et al.
Publicado: (1976)

Some Observations on an Ascitic Rous No. 1 Sarcoma
por: Bather, R.
Publicado: (1954)

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure
por: Kurtovic, Liriye, et al.
Publicado: (2019)

Observations on the Pathogenesis of Sarcoma 37 Mouse Ascites Tumour
por: Warner, P., et al.
Publicado: (1957)

Response to the letter to the editor by Dr. Tadashi Yoshida: “long noncoding RNAs: new players regulating vascular calcification?”
por: Guo, Weikang, et al.
Publicado: (2020)

Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
por: Price, M. R., et al.
Publicado: (1982)

DEVELOPMENT, PERSISTENCE, AND SIGNIFICANCE OF TYPE 2, POLIOMYELITIS COMPLEMENT-FIXING ANTIBODY IN MAN
por: Casals, Jordi, et al.
Publicado: (1952)

Leukaemic Ascites and Peritoneal Myeloid Sarcoma: Rare but Not Impossible
por: Landeiro, Luís, et al.
Publicado: (2022)

Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs.
por: Trevisani, A., et al.
Publicado: (1980)

Can complement fix placental malaria?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2021)

THE ROLE OF DISULFIDE BONDS IN THE COMPLEMENT-FIXING AND PRECIPITATING PROPERTIES OF 7S RABBIT AND SHEEP ANTIBODIES
por: Schur, Peter H., et al.
Publicado: (1964)

Sheet Formation by Cells of an Ascites Tumour in vitro
por: Trevan, D. J., et al.
Publicado: (1960)

Serum antibody responses to an ascitic variant of rat hepatoma D23.
por: Robins, R. A.
Publicado: (1975)

THE FINE STRUCTURE OF THE CELLS IN MOUSE SARCOMA 37 ASCITIC FLUIDS
por: Epstein, M. A.
Publicado: (1957)

STUDIES ON ACUTE DISSEMINATED ENCEPHALOMYELITIS PRODUCED EXPERIMENTALLY IN RHESUS MONKEYS : V. COMPLEMENT-FIXING ANTIBODIES
por: Lumsden, Charles E., et al.
Publicado: (1950)

IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS
por: Maris, Elizabeth P., et al.
Publicado: (1946)

Cannot write session to /tmp/vufind_sessions/sess_8bjeabe18tvednm5valu88079c